Last reviewed · How we verify

NCT07123168

Hierarchical Management for Maintenance Hemodialysis Patients

Completed NA Last updated 14 August 2025
What this trial tests

NA trial testing Triangle Hierarchical Management in End-stage Renal Disease (ESRD) in 80 participants. Completed in 30 November 2024.

Timeline
1 January 2024
Primary endpoint
30 November 2024
30 November 2024

Quick facts

Lead sponsorYanyan Deng
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment80
Start date1 January 2024
Primary completion30 November 2024
Estimated completion30 November 2024
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Yanyan Deng

Who can join

18 and older, any sex, with End-stage Renal Disease (ESRD). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This prospective, randomized controlled trial investigates the effectiveness of a nurse-led, Triangle Hierarchical Management model compared to routine care for patients on maintenance hemodialysis. The study aims to determine if this risk-stratified management approach improves patients' quality of life, disease-related knowledge, self-management capabilities, and treatment adherence over a 24-week period.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for End-stage Renal Disease (ESRD)

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07123168.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing